Symrise stock: Deutsche Bank cuts rating to Hold
Published on 11/21/2026 at 12:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSymrise faces a cautious analyst view
- Deutsche Bank Research downgraded Symrise from Buy to Hold on November 16, 2026.
- The bank kept its price target at 103 euros as it reviewed the outlook for European ingredients manufacturers.
Deutsche Bank Research downgraded Symrise from Buy to Hold on Monday, November 16, 2026, while keeping its price target at 103 euros. The decision gives investors a more cautious view of the specialty-chemicals group during the reporting week.
The rating change was reported by MarketScreener, which cited dpa-AFX. Analyst Virginie Boucher-Ferte said earnings expectations for European ingredients manufacturers had improved after the second quarter, but still lowered the view on Symrise and DSM-Firmenich. Deutsche Bank retained Buy ratings for Givaudan and Kerry.
Rating change adds investor focus
The decision separates Symrise from several peers in Deutsche Bank's coverage and puts greater emphasis on the company's ability to convert industry recovery into earnings growth. The unchanged target indicates that the rating shift was more cautious without a simultaneous reduction in the bank's valuation level.
Symrise stock traded at 93.88 euros on Lang & Schwarz at 12:36 CET on Saturday, November 21, 2026.
Symrise AG at a glance
- Company: Symrise AG
- ISIN: DE000SYM9999
- Latest quote: 93.88 euros on Lang & Schwarz, Saturday, November 21, 2026, at 12:36 CET
- Sector: Specialty chemicals
European equity markets remain an important backdrop for investors assessing the ingredients sector; see current market reports.
More company coverage is available in more news and analyses on Symrise stock.
